![](https://www.thescottishsun.co.uk/wp-content/uploads/sites/2/2024/07/rfmjdh-scientific-analysis-alzheimers-disease-811392683.jpg?strip=all&quality=100&w=1920&h=1080&crop=1)
‘Disappointing’ blow as ‘game-changing’ Alzheimer’s drug lecenemab is rejected by EU
EUROPE has rejected a breakthrough Alzheimer’s drug in a blow to NHS hopes. Lecanemab is one of the first medicines ever proven to destroy toxic amyloid proteins that build up in patients’ brains in early stages of the disease. 1 More than 600,000 Brits …